CEO & CMO
Senior executive leader with over 25 years global experience in development of prophylactic and therapeutic vaccines. Pierre has extended worldwide experience in a large vaccine company and in small Biotech companies, with leading roles in clinical development, regulatory & medical affairs, commercial, legal, business development.
Medical Doctor, PhD, Trop Med Dip, Pierre has expertise in vaccines, infectious diseases, immunology, auto immune and inflammatory diseases, adjuvants, with numerous publications and patents. Before joining Imcyse, Pierre was Vice-President, Chief Medical Officer, at Neovacs and Abivax, Paris, France. He was also Consultant for other Biotech companies. Before and during 18 years, Pierre has occupied various management positions in development of vaccines in GlaxoSmithKline Vaccines, Rixensart, Belgium. Pierre joined Imcyse in March 2015.
PhD, VP Head of Development
Senior executive leader with global experience in the R&D and Manufacturing Vaccine Industry. Jean is a bioengineer and owns a PhD in biochemistry. As Head of the technical development at GlaxoSmithKline Vaccines, he has developed a huge experience of the development of new vaccines with an end to end view, from the design of the antigens to the final commercial production scale. During the last 10 years he directly contributed to the development and the launch of 12 new vaccines. Before, Jean occupied various positions from project leader to general manager at Eurogentec/ Pharos, Seraing, Belgium, a Biotech Company offering services in biopharmaceutical product development and production of GMP lots for clinical trials. Jean joined Imcyse in September 2015.
Marcelle Van Mechelen
PhD, Senior Scientific Adviser
Marcelle has a 28 years experience in immunology, biotechnology and vaccinology. She owns PhD and Post Doc in immmunology on innate and adaptive immunity ULB (1987- 1995). Between 1995 and 2015, she worked in research and immunology at GSK vaccines as Vice President Vaccine Research / Research and Preclinical development GSK from 2012 onwards. Marcelle joined in March 2016.